Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Asha Murthy"'
Autor:
Emre Koca, Virginia G. Kaklamani, Adam L. Cohen, Sindhu Nair, Jorge Darcourt, Asha Murthy, Anna Belcheva, Helen Wong, Toniva Boone, Joe Ensor, Pej Hemati, Polly A. Niravath, Wei Qian, Priya V. Ramshesh, Jing Zhao, Jenny C. Chang, Tejal Patel, Xiaoxian Li
Publikováno v:
Breast Cancer Research and Treatment. 188:433-439
Neoadjuvant endocrine therapy is often utilized to downstage Estrogen Receptor-positive (ER+) breast cancer prior to surgery. However, this approach is sometimes met with endocrine resistance mechanisms within the tumor. This trial examines the safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d5dd2ca376ce58ced66f0e08ef0142
https://doi.org/10.1007/s10549-021-06214-7
https://doi.org/10.1007/s10549-021-06214-7
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311772
Background Anti-programmed cell death (PD)-1 and anti-PD-L1 medications inhibit the PD-1 and PD-L1 interaction and have been shown to be effective in treating several forms of advanced cancers. Since the approval of these agents, standard dosing prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a6c3dfb1f0f1f58b8a4b0e550a63cce
https://doi.org/10.1177/10781552231177209
https://doi.org/10.1177/10781552231177209
Autor:
Anna Belcheva, Emre Koca, Sindhu Nair, Adam L. Cohen, Wei Qian, Tejal Patel, Xiaoxian Li, Helen Wong, Jorge Darcourt, Jing Zhao, Priya V. Ramshesh, Pej Hemati, Polly A. Niravath, Jenny C. Chang, Virginia G. Kaklamani, Asha Murthy, Joe Ensor, Toniva Boone
Publikováno v:
Journal of Clinical Oncology. 37:584-584
584 Background: Neoadjuvant endocrine therapy is standard care for women with hormone receptor-positive breast cancer. However, both primary and acquired endocrine resistance is not uncommon, thereby limiting efficacy. [1] The PI3K-Akt-mTOR pathway i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8451e8235376a8044262a93e4cca52d
https://doi.org/10.1200/jco.2019.37.15_suppl.584
https://doi.org/10.1200/jco.2019.37.15_suppl.584
Percutaneous transhepatic biliary drainage in hepatopancreaticobiliary cancer: Contemporary efficacy
Autor:
Ahmed Kaseb, Vivek Subbiah, Steven Y. Huang, Asha Murthy, Ravi Murthy, Milind Javle, Varun Rachakonda, Sharjeel H. Sabir, Armeen Mahvash, Filip Janku
Publikováno v:
Journal of Clinical Oncology. 34:e21637-e21637
e21637Background: Hepatopancreaticobiliary cancers (HPBC) are increasing in incidence worldwide with most incurable at diagnosis. Local HPBC progression invariably results in malignant biliary obst...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8449ba14e0b9b897bf6838baddd38e22
https://doi.org/10.1200/jco.2016.34.15_suppl.e21637
https://doi.org/10.1200/jco.2016.34.15_suppl.e21637